Renal Cancer - Results from #60

Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting. November 7, 2024

C-reactive Protein-albumin-lymphocyte Index as a Novel Biomarker for Progression in Patients Undergoing Surgery for Renal Cancer. November 7, 2024

Immunotherapy and Tyrosine Kinase Inhibitor as a Bridge to Surgery for Clear Cell Renal Cell Carcinoma Metastases to the Thyroid: A Case Report and Literature Review. November 6, 2024

Hereditary Renal Tumor Syndromes and the Use of mTOR Inhibitors. November 6, 2024

Kidney cancer following occupational exposure to trichloroethylene: clinical case series and review of the literature. November 5, 2024

NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma. November 5, 2024

Impact of Tumor Volume and Other Factors on Renal Function After Partial Nephrectomy November 4, 2024

PrimerX: A Bayesian Multistage Cohort Embedded Randomised Trial to Evaluate the Role of Deferred Local Therapy of the Primary Tumour in Combination with Immune Checkpoint Inhibitor-based First-line Therapy in Metastatic Renal Cell Carcinoma Patients. November 4, 2024

The future of cellular therapy for the treatment of renal cell carcinoma. November 4, 2024

Efficacy and Safety of Nivolumab With Ipilimumab in Elderly Patients With Advanced Renal Cell Carcinoma. November 1, 2024

AI predictive modeling of survival outcomes for renal cancer patients undergoing targeted therapy. November 1, 2024

Treatment Modalities and Risks of Complication for Patients With Localized Renal Cell Carcinoma Aged 75 and Older. October 31, 2024

Challenges and Considerations in Modern Adjuvant Therapy Trials in Renal Cell Carcinoma: A Call to Power. October 31, 2024

Factors associated with surgical refusal and non-surgical candidacy in stage 1 kidney cancer: a National Cancer Database (NCDB) analysis. October 30, 2024

Impact of a kidney-adjusted ERAS® protocol on postoperative outcomes in patients undergoing partial nephrectomy. October 29, 2024

Meta-analysis and systematic review of factors predicting conversion to radical nephrectomy following robotic-assisted partial nephrectomy in renal cancer patients. October 29, 2024

T1a renal cancer cryoablation - first experiences in Poland. October 28, 2024

Aggressiveness classification of clear cell renal cell carcinoma using registration-independent radiology-pathology correlation learning. October 28, 2024

Low Serum Alanine Aminotransferase Blood Activity Is Associated with Shortened Survival of Renal Cell Cancer Patients and Survivors: Retrospective Analysis of 1830 Patients. October 25, 2024

Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives. October 25, 2024

Page 4 of 456